Cutler Group’s Alder Biopharmaceuticals ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-61,600
| Closed | -$10K | – | 4975 |
|
|
2019
Q3 | $10K | Buy |
+61,600
| New | +$705K | ﹤0.01% | 2657 |
|
|
2018
Q1 | – | Sell |
-17,400
| Closed | -$46K | – | 5675 |
|
|
2017
Q4 | $46K | Sell |
17,400
-9,000
| -34% | -$100K | ﹤0.01% | 1939 |
|
|
2017
Q3 | $70K | Sell |
26,400
-26,100
| -50% | -$272K | ﹤0.01% | 1953 |
|
|
2017
Q2 | $222K | Buy |
52,500
+45,800
| +684% | +$847K | 0.01% | 1194 |
|
|
2017
Q1 | $10K | Buy |
6,700
+3,400
| +103% | +$75.3K | ﹤0.01% | 4099 |
|
|
2016
Q4 | $16K | Sell |
3,300
-14,100
| -81% | -$367K | ﹤0.01% | 3727 |
|
|
2016
Q3 | $11K | Buy |
17,400
+7,800
| +81% | +$238K | ﹤0.01% | 4166 |
|
|
2016
Q2 | $34K | Sell |
9,600
-12,900
| -57% | -$349K | ﹤0.01% | 2776 |
|
|
2016
Q1 | $81K | Buy |
22,500
+10,300
| +84% | +$238K | 0.01% | 1827 |
|
|
2015
Q4 | $24K | Buy |
+12,200
| New | +$413K | ﹤0.01% | 3243 |
|
Cutler Group's ALDR Position: Q4 2019 in Review
Cutler Group sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 1,500 shares — an estimated $28K sold.
Cutler Group first reported a position in ALDR in Q4 2015 and held it in 11 quarters. The position peaked at $492K in Q2 2017. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.
- Cutler Group reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
- Cutler Group sold 1,500 Alder Biopharmaceuticals shares in Q4 2019, an estimated $28K.
- Cutler Group first reported a position in Alder Biopharmaceuticals in Q4 2015 and held it in 11 quarters.
- Cutler Group's Alder Biopharmaceuticals position peaked at $492K in Q2 2017.
- 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.
Based on Cutler Group's 13F filing for Q4 2019, filed 6 Feb 2020.